Viewing Study NCT01380756


Ignite Creation Date: 2025-12-24 @ 11:15 PM
Ignite Modification Date: 2026-02-23 @ 8:56 PM
Study NCT ID: NCT01380756
Status: COMPLETED
Last Update Posted: 2017-11-06
First Post: 2011-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Hematologic Malignancies View
None Leukemia View
None Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Amgen View
None Phase 1 View
None Clinical Trial View
None Aurora kinase inhibitor View
None Open label View
None Oncology View
None Hematology View